Business EconomyPosted at: Nov 6 2024 7:20PM


JB Pharma net up 16 percent to Rs 175 crore in Q2

New Delhi, Nov 6 (UNI) JB Chemicals & Pharmaceuticals Limited (JB Pharma) on Wednesday announced second quarter (July-September) financial performance and said its Profit After Tax grew 16 percent y-o-y to Rs 175 crore versus Rs 151 crore in the same quarter of last financial year.
JB Pharma recorded Revenue of Rs 1001 crore in the second quarter of FY25 registering growth of 13 percent from Rs 882 crores in Q2 FY24, the company said in a release.
Commenting on the financial results, Nikhil Chopra, CEO and Whole time Director, JB Pharma mentioned, “We maintained a healthy pace of growth in Q2, achieving Rs 1,000 crore revenue for the quarter. EBITDA margins at 28 percent are at the higher end of our guidance range, given a favourable product mix and cost optimization initiatives.”
JB’s domestic business continued to out-perform the market with all our major brands posting strong growth. The company has steadily driven strong volume growth for its large brands, including the acquired portfolios.
“On the international front, our formulations business performed well in Q2 and CDMO division growth will pick up in H2 as we come out of a seasonally muted Q2. JB has consistently delivered a strong revenue and margin growth. We are confident of maintaining this positive traction towards our operating and strategic goals for both this year and beyond. As we chart our future, we remain focused on making the organisation progressive and future ready,” Chopra added.
For the first six months of fiscal 2024-25, the company said that it recorded revenue of Rs 2005 crore as compared to Rs 1778 crores, registering growth of 13 percent. Profit after Tax grew 20 percent to Rs 351 crore as against Rs 293 crore in H1 FY24.
UNI SKB CS1920
Please log in to get detailed story.
Tags: #JB Pharma net up 16 percent to Rs 175 crore in Q2
More News

RBI gets lower than expected response at VRRR auctions

12 Jul 2025 | 11:34 AM

New Delhi, July 12 (UNI) Reserve Bank of India or RBI, the country’s premier central bank, conducted a seven-day auction of Variable Rate Reverse Repo or VRRR. This auction is aimed at absorbing the surplus liquidity from the whole banking system.

see more..
Selling SBI shares worth Rs 25000 cr part of privatisation: BEFI

Selling SBI shares worth Rs 25000 cr part of privatisation: BEFI

12 Jul 2025 | 8:58 AM

Thiruvananthapuram, July 12 (UNI) Bank Employees Federation of India has alleged that the Centre's move to sell shares of State Bank of India (SBI) worth Rs 25,000 crore SBI) is an open attempt to privatize the bank in a phased manner sacrificing national interests.

see more..

Mahindra Logistics to raise up to Rs 750 crore to repay debt

11 Jul 2025 | 10:50 PM

Mumbai, July 11 (UNI) Mahindra Logistics Ltd (MLL), India's leading integrated third-party logistics service provider, today informed the stock exchange in a filing that its board of directors has given its approval for raising Rs 750 crore through a rights issue.

see more..

GCCs in India driving revenue, not just cost savings

11 Jul 2025 | 10:12 PM

Bengaluru, July 11 (UNI) Global Capability Centres (GCCs) in India are undergoing a seismic shift from being cost-optimisation back offices to becoming strategic hubs for revenue generation and product innovation, said Anuj Agarwal, founder and CEO of Workplace Awards, as he unveiled what he termed the "GCC 4.0" transformation model.

see more..

Asia is playing an integral role in the Global GDP: OECD Report

11 Jul 2025 | 8:03 PM

New Delhi, July 11 (UNI) The Organization for Economic Co-Operation and Development (OECD) has highlighted the growing Asian economy behind driving the global Gross Domestic Product or GDP to a major extent. The OECD is a global organization that aims to promote policies for economic and social well-being across the world.

see more..